Trials / Terminated
TerminatedNCT00890097
Geographic Atrophy Treatment Evaluation
The Safety and Efficacy of AL-8309B Ophthalmic Solution for the Treatment of Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (AMD)
- Status
- Terminated
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 772 (actual)
- Sponsor
- Alcon Research · Industry
- Sex
- All
- Age
- 55 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study was to evaluate the safety and efficacy of AL-8309B Ophthalmic Solution versus Vehicle administered as a topical ocular drop for the treatment for geographic atrophy (GA) secondary to age-related macular degeneration (AMD).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | AL-8309B Ophthalmic Solution | |
| DRUG | AL-8309B Vehicle | Inactive ingredients used as placebo comparator |
Timeline
- Start date
- 2009-04-01
- Primary completion
- 2012-05-01
- Completion
- 2012-05-01
- First posted
- 2009-04-29
- Last updated
- 2014-07-03
- Results posted
- 2014-07-03
Source: ClinicalTrials.gov record NCT00890097. Inclusion in this directory is not an endorsement.